Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
CALL
Agilent Technologies
A
$39.1B
| $988K | ﹤0.01% |
7,700
+7,600
| +7,600% | +$918K |
|
3327
CALL
Workday
WDAY
$39.6B
| $987K | ﹤0.01% |
+4,100
| New | +$948K |
|
|
LAND
3328
Gladstone Land Corp
LAND
$350M
| $985K | ﹤0.01% |
107,556
+14,507
| +16% | +$137K |
|
3329
Solid Biosciences
SLDB
$794M
| $982K | ﹤0.01% |
159,102
-22,444
| -12% | -$131K |
|
3330
HealthStream
HSTM
$819M
| $981K | ﹤0.01% |
34,751
-12,298
| -26% | -$338K |
|
3331
Chemung Financial Corp
CHMG
$393M
| $981K | ﹤0.01% |
18,674
-1,268
| -6% | -$66.1K |
|
|
TERN
3332
DELISTED
Terns Pharmaceuticals
TERN
| $979K | ﹤0.01% |
130,391
-114,246
| -47% | -$729K |
|
|
CHA
3333
Chagee Holdings Ltd
CHA
$2.15B
| $978K | ﹤0.01% |
+59,105
| New | +$1.28M |
|
3334
Zumiez
ZUMZ
$332M
| $978K | ﹤0.01% |
49,873
-11,990
| -19% | -$198K |
|
3335
MediaAlpha
MAX
$758M
| $977K | ﹤0.01% |
85,840
-27,808
| -24% | -$307K |
|
3336
United States Antimony
UAMY
$751M
| $972K | ﹤0.01% |
156,782
-214,432
| -58% | -$896K |
|
3337
PUT
iShares US Real Estate ETF
IYR
$4.66B
| $971K | ﹤0.01% |
10,000
| – | – |
|
3338
Nature's Sunshine
NATR
$354M
| $967K | ﹤0.01% |
62,299
-742
| -1% | -$11.9K |
|
3339
Colliers International
CIGI
$5.04B
| $966K | ﹤0.01% |
6,184
-15,377
| -71% | -$2.36M |
|
3340
Shenandoah Telecom
SHEN
$664M
| $965K | ﹤0.01% |
71,930
-23,465
| -25% | -$322K |
|
3341
PUT
ASP Isotopes
ASPI
$504M
| $962K | ﹤0.01% |
100,000
| – | – |
|
3342
Daily Journal
DJCO
$809M
| $961K | ﹤0.01% |
2,066
-569
| -22% | -$247K |
|
3343
CALL
Amgen
AMGN
$208B
| $959K | ﹤0.01% |
3,400
-100,000
| -97% | -$29M |
|
|
EU
3344
enCore Energy
EU
$212M
| $959K | ﹤0.01% |
298,693
-51,201
| -15% | -$138K |
|
3345
Liberty Latin America Class A
LILA
$1.64B
| $959K | ﹤0.01% |
170,196
-31,047
| -15% | -$155K |
|
3346
Dillards
DDS
$9.19B
| $957K | ﹤0.01% |
1,558
-2,503
| -62% | -$1.29M |
|
3347
Prothena Corp
PRTA
$425M
| $957K | ﹤0.01% |
98,075
-17,773
| -15% | -$137K |
|
3348
CNB Financial Corp
CCNE
$1.04B
| $954K | ﹤0.01% |
39,432
+2,394
| +6% | +$59.1K |
|
3349
Idaho Strategic Resources
IDR
$444M
| $953K | ﹤0.01% |
28,211
-4,184
| -13% | -$98.8K |
|
3350
Nektar Therapeutics
NKTR
$2.39B
| $949K | ﹤0.01% |
16,679
+7,670
| +85% | +$254K |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.